---
schemaVersion: murph.commons.page.v1
entityType: source_artifact
key: source_artifact:ncbi-bookshelf-caffeine-cns-behavioral-effects-2026-04-26
slug: sources/caffeine-timing/ncbi-bookshelf-caffeine-cns-behavioral-effects-2026-04-26
title: Caffeine Effects on the Central Nervous System and Behavioral Effects Associated with Caffeine Consumption
summary: The chapter frames caffeine as a central nervous system adenosine antagonist and describes tolerance and withdrawal as important factors in habitual users, including possible headache, lethargy, and concentration problems after cessation or reduction.
status: draft
quality: usable
aliases:
- Caffeine Effects on the Central Nervous System and Behavioral Effects Associated with Caffeine Consumption
- source_artifact:ncbi-bookshelf-caffeine-cns-behavioral-effects-2026-04-26
categories:
- caffeine-timing
relations:
- type: related_protocol
  target: protocol_variant:caffeine-timing/caffeine-curfew-dose-reset
- type: parent_family
  target: experiment_family:caffeine-timing
source:
  kind: book
  title: Caffeine Effects on the Central Nervous System and Behavioral Effects Associated with Caffeine Consumption
  authors: Institute of Medicine; Food and Nutrition Board; Board on Health Sciences Policy; Planning Committee for a Workshop on Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements
  year: 2014
  journal: 'Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary'
  citation: 'Institute of Medicine. Caffeine Effects on the Central Nervous System and Behavioral Effects Associated with Caffeine Consumption. In: Caffeine in Food and Dietary Supplements: Examining Safety: Workshop Summary. Washington (DC): National Academies Press; 2014.'
  url: https://www.ncbi.nlm.nih.gov/books/NBK202225
sourceIdentity:
  identityKind: book
  canonicalIdBasis: url
  identifiers:
    titleHash: 7fe13d228af83b0814f0940d993615f71bc9fe246c33149319aff61794f1c5ee
    url: https://www.ncbi.nlm.nih.gov/books/NBK202225
  canonicalUrl: https://www.ncbi.nlm.nih.gov/books/NBK202225
researchEvidence:
  designKind: narrative_review
  designLabel: Workshop-summary chapter / narrative review
  populationLabel: General caffeine consumers; special discussion of adults, children, adolescents, and habitual users.
  durationLabel: Not applicable; workshop-summary background source.
  aggregateRole: context
  cohortKey: ncbi-bookshelf-caffeine-cns-behavioral-effects-2026-04-26-review-context
  notes:
  - 'Intervention or exposure: Caffeine exposure, central nervous system adenosine antagonism, tolerance, and withdrawal.'
  - 'Comparator or control: No formal comparator; mechanistic and safety background chapter.'
  - 'Effect or direction: At commonly consumed concentrations, caffeine is described as an adenosine A1 and A2A receptor antagonist; the chapter also describes tolerance and withdrawal as well-demonstrated phenomena that can influence regular consumers.'
  - 'Safety notes: Withdrawal symptoms such as headache, lethargy, and concentration problems are described; child and adolescent differences in tolerance, exposure sources, and developing brains are noted as vulnerability context.'
  - 'Population mismatch: Broad safety/mechanism source rather than a self-experiment study in adult bedtime caffeine timing.'
  - 'Limitation: Workshop-summary chapter, not a protocol trial.'
  - 'Limitation: Mechanistic and safety context cannot quantify benefit from a specific 14-day curfew.'
evidenceBucket: systematic_reviews_meta_analyses
whyItMatters: Provides the mechanistic and safety frame for why changing caffeine timing or dose can affect arousal, tolerance, and withdrawal symptoms.
potentialMurphEndpoints:
- Morning alertness
- withdrawal headache
- sleep-onset latency
- subjective energy
protocolTakeaway: Use to explain adenosine/tolerance/withdrawal rationale and to warn that abrupt caffeine reduction can cause short-term withdrawal.
murphTakeaway: Participants may need to distinguish sleep improvement from withdrawal symptoms during the first days of dose reset.
studyDesign: narrative_review
modality: mechanism-and-safety-context
claimUse: context-only
sourceFindings:
- findingId: finding:ncbi-bookshelf-caffeine-cns-adenosine-tolerance
  sourceKey: source_artifact:ncbi-bookshelf-caffeine-cns-behavioral-effects-2026-04-26
  extractedFromArtifactId: art_ncbi-bookshelf-caffeine-cns-behavioral-effects-2026-04-26_html
  findingKind: mechanistic
  population: General caffeine consumers; special discussion of adults, children, adolescents, and habitual users.
  exposure: Caffeine exposure, central nervous system adenosine antagonism, tolerance, and withdrawal.
  outcome: Adenosine receptor antagonism; alertness/arousal; tolerance; withdrawal symptoms; youth vulnerability context
  summary: The chapter frames caffeine as a central nervous system adenosine antagonist and describes tolerance and withdrawal as important factors in habitual users, including possible headache, lethargy, and concentration problems after cessation or reduction.
  evidenceUse:
  - mechanism
  - safety
  - context
- findingId: finding:ncbi-bookshelf-caffeine-cns-withdrawal-youth
  findingKind: safety
  population: Habitual caffeine consumers, with additional caution for children and adolescents.
  exposure: Caffeine reduction or cessation after regular intake; youth caffeine exposure.
  outcome: Withdrawal symptoms and population vulnerability.
  summary: The chapter describes caffeine withdrawal and physical dependence as established concerns and notes that children and adolescents differ from adults in exposure sources, lifetime caffeine experience, tolerance, and developmental vulnerability.
  evidenceUse:
  - safety
  - context
  sourceKey: source_artifact:ncbi-bookshelf-caffeine-cns-behavioral-effects-2026-04-26
  extractedFromArtifactId: art_ncbi-bookshelf-caffeine-cns-behavioral-effects-2026-04-26_html
murphV1Priority: Medium
pdfRightsStatus: open_access
---

This source is included for **systematic_reviews_meta_analyses**.

**Findings:** The chapter frames caffeine as a central nervous system adenosine antagonist and describes tolerance and withdrawal as important factors in habitual users, including possible headache, lethargy, and concentration problems after cessation or reduction.

**Why it matters:** Provides the mechanistic and safety frame for why changing caffeine timing or dose can affect arousal, tolerance, and withdrawal symptoms.

**Potential experiment signals:** Morning alertness, withdrawal headache, sleep-onset latency, subjective energy.

**Protocol takeaway:** Use to explain adenosine/tolerance/withdrawal rationale and to warn that abrupt caffeine reduction can cause short-term withdrawal.

**Claim use:** `context-only`.
